Atom Investors LP Adaptive Biotechnologies Corp Transaction History

Atom Investors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.34 - $3.96 $128,723 - $217,839	-55,010 Reduced 83.39%	10,954 $39,000
Q1 2024 May 15, 2024	BUY	$2.88 - $4.8 $189,976 - $316,627	65,964 New	65,964 $211,000
Q3 2021 Nov 15, 2021	SELL	$30.02 - $39.87 $863,405 - $1.15 Million	-28,761 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$32.22 - $44.59 $713,350 - $987,222	-22,140 Reduced 43.5%	28,761 $1.18 Million
Q1 2021 May 17, 2021	BUY	$37.26 - $67.74 $1.9 Million - $3.45 Million	50,901 New	50,901 $2.05 Million
Q3 2019 Nov 14, 2019	SELL	$30.31 - $53.51 $606,200 - $1.07 Million	-20,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$40.3 - $48.3 $806,000 - $966,000	20,000 New	20,000 $966,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.